(Q53232783)

12 May 2018

title

Clinical features and natural history of hepatocellular adenomas: the impact of obesity. (English)

1 reference

12 May 2018

0 references

9

K R Reddy

1 reference

12 May 2018

C Bunchorntavakul

1

1 reference

12 May 2018

R Bahirwani

2

1 reference

12 May 2018

D Drazek

3

1 reference

12 May 2018

M C Soulen

4

1 reference

12 May 2018

E S Siegelman

5

1 reference

12 May 2018

E E Furth

6

1 reference

12 May 2018

K Olthoff

7

1 reference

12 May 2018

A Shaked

8

1 reference

12 May 2018

language of work or name

English

0 references

publication date

15 July 2011

1 reference

12 May 2018

Alimentary Pharmacology & Therapeutics

published in

1 reference

12 May 2018

volume

34

1 reference

12 May 2018

issue

6

1 reference

12 May 2018

page(s)

664-674

1 reference

12 May 2018

Case-orientated approach to the management of hepatocellular adenoma.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Liver-Cell Adenomas Associated with Use of Oral Contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Epidemiology of hepatocellular adenoma. The role of oral contraceptive use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Biologic and clinical features of benign solid and cystic lesions of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Benign hepatocellular tumors (adenomatosis) in nonalcoholic steatohepatitis: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Telangiectatic adenoma: an entity associated with increased body mass index and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Multiple hepatic adenomas associated with liver steatosis at CT and MRI: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Liver adenomatosis: re-evaluation of aetiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Metabolic syndrome and NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Possible association between benign hepatomas and oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Prevalence and trends in obesity among US adults, 1999-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Combination contraceptives: effects on weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Contraceptive considerations in obese women: release date 1 September 2009, SFP Guideline 20091.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Impact of steatosis on perioperative outcome following hepatic resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Hormonal contraceptive use among women with liver tumors: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Asymptomatic liver cell adenomas. Another case of resolution after discontinuation of oral contraceptive use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

The prevalence and features of the polycystic ovary syndrome in an unselected population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Hepatocellular adenoma: what is new in 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Selective transcatheter arterial embolization for treatment of bleeding complications or reduction of tumor mass of hepatocellular adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

A Single-Center Surgical Experience of 122 Patients With Single and Multiple Hepatocellular Adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

Changing trends in malignant transformation of hepatocellular adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04772.X

10.1111/J.1365-2036.2011.04772.X

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018